RNA Leaders

SomaGenics' RNA detection program has developed next-generation sequencing kits and qPCR technologies for the most accurate microRNA quantification currently available. Our therapeutics program focuses on developing novel RNA-centered approaches that address unmet medical needs. SomaGenics' research and development has been supported by over $ 25M in competitive grants. Our staff includes internationally recognized leaders in RNA research and technology development. Learn more...

more about SomaGenics

Latest from SomaGenics


SomaGenics awarded NIH funding to develop NGS Single-Cell analysis of small RNAs

Santa Cruz, CA, October 2017- SomaGenics announced the receipt of a Phase I SBIR grant from NIH to develop RealSeq®-SC (Single Cell), expected to be the first commercially available library...

Read more

SomaGenics is a privately held biotech company with offices and laboratories located in Santa Cruz, CA. We specialize in small RNA technologies, including innovative RNAi-based therapeutics using sshRNA molecules, and diagnostics/biomarker detection of small or fragmented RNA, including microRNAs.

learn more